TARSONS NSE filing

Tarsons Products Q1 FY27 Results: Board Approves Unaudited Financials & Sets AGM Date

The RealCase readMedium impact Neutral

Tarsons Products' Board approved Q1 FY27 unaudited results on August 10, 2026. The 43rd AGM is set for September 24, 2026, with e-voting cut-off on September 17, 2026. Consolidated profit before tax was ₹32.4 million, and standalone profit before tax was ₹5.2 million for the quarter ended June 30, 2026.

Why it matters

The approval of quarterly results and the scheduling of the AGM are routine corporate actions. However, the AGM date and e-voting cut-off are important for shareholders, and the financial results provide key performance indicators for the company.

The market read

The announcement details the approval of financial results and the schedule for the Annual General Meeting. While the results themselves are factual, they do not contain significant positive or negative surprises that would strongly influence sentiment.

Tarsons Products Limited announced the outcome of its Board meeting held on August 10, 2026. The Board approved the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The company's 43rd Annual General Meeting (AGM) is scheduled to be held via video conferencing on Thursday, September 24, 2026, at 12:00 P.M. IST.

The cut-off date for e-voting at the AGM has been fixed as Thursday, September 17, 2026. The Annual Report and Notice of the AGM will be shared with stock exchanges and members in due course and will also be hosted on the company's website, www.tarsons.com.

The financial results for the quarter ended June 30, 2026, show consolidated total income of ₹1062.21 million and a profit before tax of ₹32.4 million. Standalone total income was ₹920.01 million with a profit before tax of ₹5.2 million. The company's financial statements were reviewed by Price Waterhouse Chartered Accountants LLP.

Filing to action

What to do with a filing like this

Tarsons Products Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by Tarsons Products Limited. Read the original for the full detail.

View original filing